期刊文献+

miR-125a-5p与肺结核关系的研究进展

Research Progress on the Relationship between miR-125a-5p and Pulmonary Tuberculosis
下载PDF
导出
摘要 肺结核(pulmonary tuberculosis, PTB)指的是由结核分枝杆菌引发的肺部感染性疾病,是严重威胁人类健康的疾病。结核分枝杆菌感染后绝大多数感染者处于结核分枝杆菌潜伏感染(Latent tuberculo-sis infection, LTBI)状态,5%~10%的LTBI者一生中会发展为活动性结核病。miR-125a-5p是一种微小RNA分子亚型,研究显示miR-125a-5p对肺结核的发生发展及转归具有重要作用。本文介绍了miR-125a-5p调控巨噬细胞极化及炎症反应,总结了miR-125a-5p与肺结核的关联性,认为miR-125a-5p对肺结核患者的诊治有一定指导意义。 Tuberculosis (pulmonary tuberculosis, PTB) refers to the pulmonary infectious disease caused by Mycobacterium tuberculosis, which is a serious threat to human health disease. After mycobacte-rium tuberculosis infection, the vast majority of infected people are in the latent mycobacterium tuberculosis infection (Latent tuberculosis infection, LTBI) status, and 5% to 10% of LTBI patients will develop active TB during their lifetime. As miR-125a-5p is a tiny RNA molecular subtype, stud-ies showed that miR-125a-5p plays an important role in the development and outcome of pulmo-nary tuberculosis. This paper introduces the regulation of macrophage polarization by miR-125a-5p and inflammatory response, summarizes the association of miR-125a-5p and pulmonary tuberculo-sis, and believes that miR-125a-5p has some guidance for the diagnosis and treatment of pulmo-nary tuberculosis patients.
作者 刘荣 久太
出处 《临床医学进展》 2023年第5期7410-7416,共7页 Advances in Clinical Medicine
  • 相关文献

参考文献4

二级参考文献82

  • 1Kaufmann SH. How can immunology contribute to the control of tuberculosis[J].Nature Reviews Immunology,2001,(01):20-30.doi:10.1038/35095558.
  • 2Wajant H,Pfizenmaier K,Scheurich P. Tumor necrosis factor signaling[J].Cell Death and Differentiation,2003,(01):45-65.doi:10.1038/sj.cdd.4401189.
  • 3Black RA,Rauch CT,Kozlosky CJ. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells[J].Nature,1997,(6618):729-733.doi:10.1038/385729a0.
  • 4Grell M,Douni E,Wajant H. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor[J].Cell,1995,(05):793-802.
  • 5Mootoo A,Stylianou E,Arias MA. TNF-alpha in tuberculosis:a cytokine with a split personality (Review)[J].INFLAMMATION & ALLERGY DRUG TARGETS,2009,(01):53-62.
  • 6North R J,Jung YJ. Immunity to tuberculosis(Review)[J].Annual Review of Immunology,2004.599-623.
  • 7Girardi E,Raviglione MC,Antonucci G. Impact of the HIV epidemic on the spread of other diseases:the case of tuberculosis[J].Aids,2000,(Suppl 3):S47-S56.
  • 8Whalen C,Horsburgh CR Jr,Hom D. Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis[J].Aids,1997,(04):455-460.
  • 9Wallis RS. Tumour necrosis factor antagonists:structure,function,and tuberculosis risks[J].Lancet Infectious Diseases,2008,(10):601-611.
  • 10Flynn JI,Chan J. Immunology of tuberculosis[J].Annual Review of Immunology,2001.93-129.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部